CompletedNot Applicable

Eye Alignment and Eye Control Changes Through Follow up Period After Application of Eye Exercises Post Strabismus Surgery

Egypt40 participantsStarted 2024-08-15

Plain-language summary

The aim of this study is to determine the patient status through its follow up period and weather the eye alignment and eye control are as the same as the last physiotherapy treatment session or there is any deterioration of them.

Who can participate

Age range

5 Years – 15 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients are both males and females. * Their age will range from (5-15) years. * All Patients received physiotherapy training for improving eye alignment and eye control. * Patients applied the physiotherapy rehabilitation program for 3 months with the physiotherapist. * All Patients complete their physiotherapy training sessions for improving eye alignment and eye control * All Patients have a history of strabismus surgery. * Intermittent exotropia was the type of strabismus which included to the study. Exclusion Criteria: * \- Patient who didn't receive physiotherapy training program for improving eye control and eye alignment post strabismus surgery. * Patient who didn't complete the physiotherapy training program for 3 months. * Muscular disorders that will impair performance during training. * Any organic lesion in the eye. * Neurological disorders. * Malignant conditions. * Psychiatric illness, severe behavior or cognitive disorders.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Eye deviation by prism-cover test

Timeframe: 3 months

Measurement of eye control by Intermittent Exotropia Control Scale

Timeframe: 3 months

Trial details

NCT IDNCT06543212

SponsorAmany Refaat Mohamed Abdel Wahid

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-15

View on ClinicalTrials.gov More Strabismus; Intermittent trials

Who can participate

Age range

5 Years – 15 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.